Efficacy and Safety of different formulations of LAS 41004 compared to active control and placebo

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-000186-13

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective of the study is to gain an indication of efficacy for five distinct combinations of bexarotene and betamethasone dipropionate in different concentrations, and one combination of tazarotene and betamethasone dipropionate compared to bland ointment (Vaseline®) and Daivobet® -ointment in the treatment of Plaque-Type Psoriasis. This is accomplished by comparison of the treatment areas over time as assessed by the area under the curve of the width of the echo-lucent band located at the dermo-epidermal junction, as measured by ultrasound at visits 1, 4, 8 and 11, as the primary endpoint.


Critère d'inclusion

  • Plaque-type psoriasis (psoriasis vulgaris) for at least 12 months

Liens